Loading the map…

Other service activities n.e.c. · Maidstone, Kent

Pure Pharma

Pure Pharma Ltd

ActiveLatest figures: 2025Abridged accountsCompany only3 years on the register

Private limited company registered in Maidstone, classed under “Other service activities n.e.c.”.

Headline figures

FY to Sept 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20242025
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet20242025
Current assets
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

4 balance-sheet lines and 2 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Pure Pharma do?

Private limited company registered in Maidstone, classed under “Other service activities n.e.c.”.

›How much turnover does Pure Pharma make?

Answered in the full report

›Is Pure Pharma profitable?

Pure Pharma's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Pure Pharma?

Answered in the full report

›Where is Pure Pharma based?

Its registered office is 13 Bella Rosa Drive, Langley, Maidstone, Kent, ME17 3US, in Maidstone, Kent.

›When was Pure Pharma founded?

Pure Pharma Ltd was incorporated on 7 September 2023.

›Is Pure Pharma still trading?

The register lists Pure Pharma Ltd as active.